Pterostilbene surpassed resveratrol for anti-inflammatory application: Potency consideration and pharmacokinetics perspective

Journal of Functional Foods

Volumn 11, Issue C, 2014, Pages 352-362

  Choo, Qiu Yi ^a,c   Yeo, Samuel Chao Ming ^a   Ho, Paul C ^a   Tanaka, Yoshiya ^b   Lin, Hai Shu ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c HEALTH SCIENCES AUTHORITY   (Singapore)

Author keywords

Anti inflammation; Bio distribution; Pharmacokinetics after repeated dosing; Pterostilbene; Resveratrol

Indexed keywords

RATTUS;

EID: 84926372192     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.10.018     Document Type: Article

References (55)

1. Abe M., Tanaka Y., Saito K., Shirakawa F., Koyama Y., Goto S., Eto S. Regulation of interleukin (IL)-1beta gene transcription induced by IL-1beta in rheumatoid synovial fibroblast-like cells, E11, transformed with simian virus 40 large T antigen. Journal of Rheumatology 1997, 24:420-429.
2. Azzolini M., Spina M.L., Mattarei A., Paradisi C., Zoratti M., Biasutto L. Pharmacokinetics and tissue distribution of pterostilbene in the rat. Molecular Nutrition & Food Research 2014.
3. Bauerova K., Ponist S., Mihalova D., Drafi F., Kuncirova V. Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress. Interdisciplinary Toxicology 2011, 4:33-39.
4. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nature Reviews Drug Discovery 2006, 5:493-506.
5. Braithwaite M.C., Tyagi C., Tomar L.K., Kumar P., Choonara Y.E., Pillay V. Nutraceutical-based therapeutics and formulation strategies augmenting their efficiency to complement modern medicine: An overview. Journal of Functional Foods 2014, 6:82-99.
6. Byun H.S., Song J.K., Kim Y.R., Piao L., Won M., Park K.A., Choi B.L., Lee H., Hong J.H., Park J., Seok J.H., Lee Y.J., Kang S.W., Hur G.M. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford, England) 2008, 47:301-308.
7. Carey A.N., Fisher D.R., Rimando A.M., Gomes S.M., Bielinski D.F., Shukitt-Hale B. Stilbenes and anthocyanins reduce stress signaling in BV-2 mouse microglia. Journal of Agricultural and Food Chemistry 2013, 61:5979-5986.
8. Chang J., Rimando A., Pallas M., Camins A., Porquet D., Reeves J., Shukitt-Hale B., Smith M.A., Joseph J.A., Casadesus G. Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. Neurobiology of Aging 2012, 33:2062-2071.
9. Chen X., Lu J., An M., Ma Z., Zong H., Yang J. Anti-inflammatory effect of resveratrol on adjuvant arthritis rats with abnormal immunological function via the reduction of cyclooxygenase-2 and prostaglandin E2. Molecular Medicine Reports 2014, 9:2592-2598.
10. Chen X.Y., Wang Z.C., Li J., Liu X.L., Sun Y.H. Regulation of synoviocyte activity by resveratrol in rats with adjuvant arthritis. Experimental and Therapeutic Medicine 2013, 6:172-176.
11. Cheng A.S., Cheng Y.H., Chang T.L. Resveratrol protects RINm5F pancreatic cells from methylglyoxal-induced apoptosis. Journal of Functional Foods 2013, 5:1774-1783.
12. Chiou Y.S., Tsai M.L., Nagabhushanam K., Wang Y.J., Wu C.H., Ho C.T., Pan M.H. Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. Journal of Agricultural and Food Chemistry 2011, 59:2725-2733.
13. Choo Q.Y., Ho P.C., Tanaka Y., Lin H.S. Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells. Rheumatology (Oxford, England) 2010, 49:1447-1460.
14. Choo Q.Y., Ho P.C., Tanaka Y., Lin H.S. The histone deacetylase inhibitors MS-275 and SAHA suppress the p38 mitogen-activated protein kinase signaling pathway and chemotaxis in rheumatoid arthritic synovial fibroblastic E11 cells. Molecules 2013, 18:14085-14095.
15. Cullberg K.B., Foldager C.B., Lind M., Richelsen B., Pedersen S.B. Inhibitory effects of resveratrol on hypoxia-induced inflammation in 3T3-L1 adipocytes and macrophages. Journal of Functional Foods 2014, 7:171-179.
16. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. Journal of Immunology 1988, 141:2407-2412.
17. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
18. Firestein G.S. NF-kappa B: Holy grail for rheumatoid arthritis?. Arthritis and Rheumatism 2004, 50:2381-2386.
19. Hou Y., Xie G., Miao F., Ding L., Mou Y., Wang L., Su G., Chen G., Yang J., Wu C. Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Progress in Neuro-psychopharmacology & Biological Psychiatry 2014.
20. Hsu C.L., Lin Y.J., Ho C.T., Yen G.C. Inhibitory effects of garcinol and pterostilbene on cell proliferation and adipogenesis in 3T3-L1 cells. Food & Function 2012, 3:49-57.
21. Hsu C.L., Lin Y.J., Ho C.T., Yen G.C. The inhibitory effect of pterostilbene on inflammatory responses during the interaction of 3T3-L1 adipocytes and RAW 264.7 macrophages. Journal of Agricultural and Food Chemistry 2013, 61:602-610.
22. Huber L.C., Distler O., Tarner I., Gay R.E., Gay S., Pap T. Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology (Oxford, England) 2006, 45:669-675.
23. Joseph J.A., Fisher D.R., Cheng V., Rimando A.M., Shukitt-Hale B. Cellular and behavioral effects of stilbene resveratrol analogues: Implications for reducing the deleterious effects of aging. Journal of Agricultural and Food Chemistry 2008, 56:10544-10551.
24. Kapetanovic I.M., Muzzio M., Huang Z., Thompson T.N., McCormick D.L. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemotherapy and Pharmacology 2011, 68:593-601.
25. Kopec A., Piatkowska E., Leszczynska T., Koronowicz A. Effect of long term administration of resveratrol on lipid concentration in selected organs and liver's histology in rats fed high fructose diet. Journal of Functional Foods 2013, 5:299-305.
26. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 358:903-911.
27. Lee M.F., Liu M.L., Cheng A.C., Tsai M.L., Ho C.T., Liou W.S., Pan M.H. Pterostilbene inhibits dimethylnitrosamine-induced liver fibrosis in rats. Food Chemistry 2013, 138:802-807.
28. Lefevre S., Knedla A., Tennie C., Kampmann A., Wunrau C., Dinser R., Korb A., Schnaker E.M., Tarner I.H., Robbins P.D., Evans C.H., Sturz H., Steinmeyer J., Gay S., Scholmerich J., Pap T., Muller-Ladner U., Neumann E. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nature Medicine 2009, 15:1414-1420.
29. Li K., Dias S.J., Rimando A.M., Dhar S., Mizuno C.S., Penman A.D., Lewin J.R., Levenson A.S. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PLoS ONE 2013, 8:e57542.
30. Li X., Makarov S.S. An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:17432-17437.
31. Liang L., Liu X., Wang Q., Cheng S., Zhang S., Zhang M. Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4'-tri-O-acetylresveratrol in rats. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2013, 20:558-563.
32. Lin C.Y., Hsiao W.C., Wright D.E., Hsu C.L., Lo Y.C., Hsu G.S.W., Kao C.F. Resveratrol activates the histone H2B ubiquitin ligase, RNF20, in MDA-MB-231 breast cancer cells. Journal of Functional Foods 2013, 5:790-800.
33. Lin H.S., Ho P.C. A rapid HPLC method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2009, 49:387-392.
34. Lin H.S., Ho P.C. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in Sprague-Dawley rats: The impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability. Journal of Pharmaceutical Sciences 2011, 100:4491-4500.
35. Lin H.S., Yue B.D., Ho P.C. Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomedical Chromatography 2009, 23:1308-1315.
36. Macickova T., Drabikova K., Nosal R., Bauerova K., Mihalova D., Harmatha J., Pecivova J. In vivo effect of pinosylvin and pterostilbene in the animal model of adjuvant arthritis. Neuro Endocrinology Letters 2010, 31(Suppl. 2):91-95.
37. Makarov S.S. NF-kappa B in rheumatoid arthritis: A pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Research 2001, 3:200-206.
38. Nakahara H., Song J., Sugimoto M., Hagihara K., Kishimoto T., Yoshizaki K., Nishimoto N. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis and Rheumatism 2003, 48:1521-1529.
39. Nakatsuka K., Tanaka Y., Hubscher S., Abe M., Wake A., Saito K., Morimoto I., Eto S. Rheumatoid synovial fibroblasts are stimulated by the cellular adhesion to T cells through lymphocyte function associated antigen-1/intercellular adhesion molecule-1. Journal of Rheumatology 1997, 24:458-464.
40. Nakayama H., Yaguchi T., Yoshiya S., Nishizaki T. Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent manner. Rheumatology International 2012, 32:151-157.
41. Nelson R.D., Quie P.G., Simmons R.L. Chemotaxis under agarose: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. Journal of Immunology 1975, 115:1650-1656.
42. Pan M.H., Chang Y.H., Tsai M.L., Lai C.S., Ho S.Y., Badmaev V., Ho C.T. Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Journal of Agricultural and Food Chemistry 2008, 56:7502-7509.
43. Pari L., Satheesh M.A. Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats. Life Sciences 2006, 79:641-645.
44. Perecko T., Drabikova K., Lojek A., Ciz M., Ponist S., Bauerova K., Nosal R., Harmatha J., Jancinova V. The effects of pterostilbene on neutrophil activity in experimental model of arthritis. BioMed Research International 2013, 2013:106041.
45. Poulsen M.M., Ornstrup M.J., Harslof T., Jessen N., Langdahl B.L., Richelsen B., Jorgensen J.O.L., Pedersen S.B. Short-term resveratrol supplementation stimulates serum levels of bone-specific alkaline phosphatase in obese non-diabetic men. Journal of Functional Foods 2014, 6:305-310.
46. Remsberg C.M., Yanez J.A., Ohgami Y., Vega-Villa K.R., Rimando A.M., Davies N.M. Pharmacometrics of pterostilbene: Preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytotherapy Research 2008, 22:169-179.
47. Riche D.M., McEwen C.L., Riche K.D., Sherman J.J., Wofford M.R., Deschamp D., Griswold M. Analysis of safety from a human clinical trial with pterostilbene. Journal of Toxicology 2013, 2013:463595.
48. Rimando A.M., Nagmani R., Feller D.R., Yokoyama W. Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. Journal of Agricultural and Food Chemistry 2005, 53:3403-3407.
49. Roupe K.A., Yanez J.A., Teng X.W., Davies N.M. Pharmacokinetics of selected stilbenes: Rhapontigenin, piceatannol and pinosylvin in rats. Journal of Pharmacy and Pharmacology 2006, 58:1443-1450.
50. Ruiz M.J., Fernandez M., Pico Y., Manes J., Asensi M., Carda C., Asensio G., Estrela J.M. Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. Journal of Agricultural and Food Chemistry 2009, 57:3180-3186.
51. Shi Y.W., Wang C.P., Liu L., Liu Y.L., Wang X., Hong Y., Li Z., Kong L.D. Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice. Molecular Nutrition & Food Research 2012, 56:1433-1444.
52. Xuzhu G., Komai-Koma M., Leung B.P., Howe H.S., McSharry C., McInnes I.B., Xu D. Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Annals of the Rheumatic Diseases 2012, 71:129-135.
53. Yeo S.C., Ho P.C., Lin H.S. Pharmacokinetics of pterostilbene in Sprague-Dawley rats: The impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability. Molecular Nutrition & Food Research 2013, 57:1015-1025.
54. Yoshifuji H., Umehara H., Maruyama H., Itoh M., Tanaka M., Kawabata D., Fujii T., Mimori T. Amelioration of experimental arthritis by a calpain-inhibitory compound: Regulation of cytokine production by E-64-d in vivo and in vitro. International Immunology 2005, 17:1327-1336.
55. Zhang L., Zhou G., Song W., Tan X., Guo Y., Zhou B., Jing H., Zhao S., Chen L. Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo. Apoptosis: An International Journal on Programmed Cell Death 2012, 17:25-36.